PlainRecalls
FDA Drug Low Class III Terminated

Famotidine for Oral Suspension, USP 40 mg/5 mL, Rx Only, Cherry-Banana-Mint Flavored, Not for Injection, Manufactured by: Novel Laboratories, Inc., Somerset, NJ 08873. Distributed by: Gavis Pharmaceuticals, LLC, Somerset, NJ 08873, NDC 43386-500-11.

Reported: September 3, 2014 Initiated: June 20, 2014 #D-1484-2014

Product Description

Famotidine for Oral Suspension, USP 40 mg/5 mL, Rx Only, Cherry-Banana-Mint Flavored, Not for Injection, Manufactured by: Novel Laboratories, Inc., Somerset, NJ 08873. Distributed by: Gavis Pharmaceuticals, LLC, Somerset, NJ 08873, NDC 43386-500-11.

Reason for Recall

Failed Impurity/Degradation Specification; 12-month stability time point

Details

Recalling Firm
Novel Laboratories, Inc.
Units Affected
25,776 containers
Distribution
Nationwide
Location
Somerset, NJ

Frequently Asked Questions

What product was recalled?
Famotidine for Oral Suspension, USP 40 mg/5 mL, Rx Only, Cherry-Banana-Mint Flavored, Not for Injection, Manufactured by: Novel Laboratories, Inc., Somerset, NJ 08873. Distributed by: Gavis Pharmaceuticals, LLC, Somerset, NJ 08873, NDC 43386-500-11.. Recalled by Novel Laboratories, Inc.. Units affected: 25,776 containers.
Why was this product recalled?
Failed Impurity/Degradation Specification; 12-month stability time point
Which agency issued this recall?
This recall was issued by the FDA Drug on September 3, 2014. Severity: Low. Recall number: D-1484-2014.